SOURCE: Event Cardio Group

Event Cardio Group

February 26, 2016 08:00 ET

NowCardio Receives Certification

NEW YORK, NY--(Marketwired - February 26, 2016) - Event Cardio Group Inc. (OTCQB: ECGI), a medical device company, is pleased to announce that its (Advanced Ambulatory Arrhythmia Monitoring System), NowCardio™, has successfully been certified to Canadian Medical Devices Conformity Assessment System (CMDCAS), ISO 13485:2003, and ISO 9001:2008. The certification was performed by a recognized registrar, BSI Group, and is a significant advancement towards the commercialization of NowCardio™ within North American Markets.

NowCardio™ is an (Advanced Ambulatory Arrhythmia Monitoring System) that will be used to monitor, analyze, record, and transmit a patient's heart's physiological data in real-time. NowCardio™ offers the functionality of Holter Monitoring, Event Recording, and Mobile Cardiac Telemetry all within a single device. The NowCardio™ system is configurable, enabling a single device to serve multiple segments within the Cardiac Diagnostic Marketplace.

John Bentivoglio, Chief Executive Officer and President of Event Cardio Group, stated, "The certification is a major milestone for NowCardio™ and we are moving forward with our commercialization plan to bring this innovative product to market in 2016. We believe that NowCardio™ is positioned to be a game changer within the Cardiac Diagnostic Marketplace. "

About Event Cardio Group Inc.

Event Cardio Group Inc. is a developer of medical diagnostic detection equipment that focuses on the detection, and preventive treatment, of high-risk diseases. The Company's core product is NowCardio™, an advanced cardiac monitor which offers the combined functionality of holter monitoring, event recording, and mobile cardiac telemetry simultaneously within a single device. For more information on the company please visit

Contact Information

  • Contact:

    John Bentivoglio
    President & CEO
    Event Cardio Group Inc.